Skip to main content
Erschienen in: European Journal of Pediatrics 3/2018

22.12.2017 | Original Article

Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center

verfasst von: Arne Simon, Markus Mock, Norbert Graf, Lutz von Müller

Erschienen in: European Journal of Pediatrics | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

In a German pediatric oncology unit, the attending physicians diagnosed 27 cases of Clostridium difficile-associated disease (CDI) from January 01, 2010 to October 31, 2013. This refers to a CDI incidence density of 2.0/1000 inpatient days. According to the hospital hygiene standard, symptomatic patients with CDI were kept in contact isolation. Most patients (median age 8.2 years) suffered from acute lymphoblastic leukemia; 88.9% were treated with broad-spectrum antibiotics during the preceding 4 weeks. 29.6% received intravenous morphine/metamizole and parenteral nutrition due to severe chemotherapy-induced mucositis. None of the patients experienced severe complications such as lower gastrointestinal tract bleeding, sepsis, or toxic megacolon. Genotyping of the isolates derived from symptomatic patients revealed many different ribotypes without detection of the hypervirulent 027 strain and did not point at hospital transmission as an important promoter of CDI in our unit.
Conclusion: Under strict standard hygiene and contact isolation for symptomatic patients, genotyping of clinical isolates revealed that in pediatric cancer patients, CDI is not necessarily based on nosocomial transmission. The rate of CDI-related severe complications was low.
What is Known:
Pediatric cancer patients face an increased risk of Clostridium difficile-associated disease due to immunosuppression, cancer chemotherapy, mucositis, and dysbiosis following intravenous broad-spectrum antimicrobial treatment.
C. difficile may be transmitted from patient to patient.
What is New:
Under strict standard hygiene and contact isolation for symptomatic patients, genotyping of clinical isolates revealed that in pediatric cancer patients, CDI is not necessarily based on nosocomial transmission.
The rate of CDI-related severe complications was low.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Dantes R, Epson EE, Dominguez SR, Dolan S, Wang F, Hurst A, Parker SK, Johnston H, West K, Anderson L, Rasheed JK, Moulton-Meissner H, Noble-Wang J, Limbago B, Dowell E, Hilden JM, Guh A, Pollack LA, Gould CV (2016) Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting. Am J Infect Control 44(2):138–145. https://doi.org/10.1016/j.ajic.2015.09.004 CrossRefPubMed Dantes R, Epson EE, Dominguez SR, Dolan S, Wang F, Hurst A, Parker SK, Johnston H, West K, Anderson L, Rasheed JK, Moulton-Meissner H, Noble-Wang J, Limbago B, Dowell E, Hilden JM, Guh A, Pollack LA, Gould CV (2016) Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting. Am J Infect Control 44(2):138–145. https://​doi.​org/​10.​1016/​j.​ajic.​2015.​09.​004 CrossRefPubMed
5.
Zurück zum Zitat Dominguez SR, Dolan SA, West K, Dantes RB, Epson E, Friedman D, Littlehorn CA, Arms LE, Walton K, Servetar E, Frank DN, Kotter CV, Dowell E, Gould CV, Hilden JM, Todd JK (2014) High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients. Clin Infect Dis 59(3):401–403. https://doi.org/10.1093/cid/ciu302 CrossRefPubMed Dominguez SR, Dolan SA, West K, Dantes RB, Epson E, Friedman D, Littlehorn CA, Arms LE, Walton K, Servetar E, Frank DN, Kotter CV, Dowell E, Gould CV, Hilden JM, Todd JK (2014) High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients. Clin Infect Dis 59(3):401–403. https://​doi.​org/​10.​1093/​cid/​ciu302 CrossRefPubMed
7.
Zurück zum Zitat Fisher BT, Sammons JS, Li Y, de Blank P, Seif AE, Huang YS, Kavcic M, Klieger S, Harris T, Torp K, Rheam D, Shah A, Aplenc R (2014) Variation in risk of hospital-onset Clostridium difficile infection across beta-lactam antibiotics in children with new-onset acute lymphoblastic leukemia. J Pediatric Infect Dis Soc 3(4):329–335. https://doi.org/10.1093/jpids/piu008 CrossRefPubMedPubMedCentral Fisher BT, Sammons JS, Li Y, de Blank P, Seif AE, Huang YS, Kavcic M, Klieger S, Harris T, Torp K, Rheam D, Shah A, Aplenc R (2014) Variation in risk of hospital-onset Clostridium difficile infection across beta-lactam antibiotics in children with new-onset acute lymphoblastic leukemia. J Pediatric Infect Dis Soc 3(4):329–335. https://​doi.​org/​10.​1093/​jpids/​piu008 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, Hakim H, Santolaya M, Castagnola E, Davis BL, Dupuis LL, Gibson F, Groll AH, Gaur A, Gupta A, Kebudi R, Petrilli S, Steinbach WJ, Villarroel M, Zaoutis T, Sung L (2012) Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol 30(35):4427–4438. https://doi.org/10.1200/JCO.2012.42.7161 [doi] CrossRefPubMed Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, Hakim H, Santolaya M, Castagnola E, Davis BL, Dupuis LL, Gibson F, Groll AH, Gaur A, Gupta A, Kebudi R, Petrilli S, Steinbach WJ, Villarroel M, Zaoutis T, Sung L (2012) Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol 30(35):4427–4438. https://​doi.​org/​10.​1200/​JCO.​2012.​42.​7161 [doi] CrossRefPubMed
14.
Zurück zum Zitat Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel P, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer M (2008) Nosocomial infections in pediatric cancer patients: results of a prospective surveillance study from 7 university hospitals in Germany and Switzerland. BMC Infect Dis E-Pub (8):70 Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel P, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer M (2008) Nosocomial infections in pediatric cancer patients: results of a prospective surveillance study from 7 university hospitals in Germany and Switzerland. BMC Infect Dis E-Pub (8):70
18.
Zurück zum Zitat van Vliet MJ, Tissing WJ, Dun CA, Meessen NE, Kamps WA, de Bont ES, Harmsen HJ (2009) Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49(2):262–270. https://doi.org/10.1086/599346 [doi] CrossRefPubMed van Vliet MJ, Tissing WJ, Dun CA, Meessen NE, Kamps WA, de Bont ES, Harmsen HJ (2009) Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49(2):262–270. https://​doi.​org/​10.​1086/​599346 [doi] CrossRefPubMed
20.
Zurück zum Zitat von Muller L, Mock M, Halfmann A, Stahlmann J, Simon A, Herrmann M (2015) Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. Int J Med Microbiol 305(7):807–813. https://doi.org/10.1016/j.ijmm.2015.08.035 CrossRef von Muller L, Mock M, Halfmann A, Stahlmann J, Simon A, Herrmann M (2015) Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. Int J Med Microbiol 305(7):807–813. https://​doi.​org/​10.​1016/​j.​ijmm.​2015.​08.​035 CrossRef
Metadaten
Titel
Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center
verfasst von
Arne Simon
Markus Mock
Norbert Graf
Lutz von Müller
Publikationsdatum
22.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 3/2018
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-017-3070-1

Weitere Artikel der Ausgabe 3/2018

European Journal of Pediatrics 3/2018 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.